Certolizumab pegol in active rheumatoid arthritis

被引：0
|
作者：
Aarat M. Patel
Larry W. Moreland
机构：
[1] University of Pittsburgh,Division of Rheumatology and Clinical Immunology, Division of Pediatric Rheumatology
[2] Children’s Hospital,Division of Rheumatology and Clinical Immunology
[3] University of Pittsburgh,undefined
来源：
Current Rheumatology Reports | 2009年 / 11卷 / 5期
关键词：
Adalimumab; Active Rheumatoid Arthritis; Certolizumab Pegol; ACR20 Response Rate; Total Sharp Score;
D O I：
10.1007/s11926-009-0056-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 312
页数：1
相关论文
共 50 条
  • [41] BUDGET IMPACT ANALYSIS OF CERTOLIZUMAB PEGOL IN THE MANAGEMENT OF PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS IN GREECE
    Tzanetakos, C.
    Maniadakis, N.
    Kourlaba, G.
    Tzioufas, A.
    Goules, A.
    Theodoratou, T.
    Christou, P.
    VALUE IN HEALTH, 2014, 17 (07) : 375 - 375
  • [42] Efficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Iwai, Koichi
    Sakamaki, Yoshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S476 - S476
  • [43] Certolizumab pegol for the treatment of psoriatic arthritis
    Hansen, Renata Baronaite
    Kavanaugh, Arthur
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (03) : 307 - 318
  • [44] Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis
    Soriano, Enrique R.
    Dellepiane, Analia
    Salvatierra, Gabriela
    Alejandro Benitez, Cristian
    Garcia Salinas, Rodrigo
    Baruzzo, Carlos
    FUTURE SCIENCE OA, 2018, 4 (04):
  • [45] EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME AT ONE YEAR
    Berenbaum, F.
    Pham, T.
    Fautrel, B.
    Joubert, J. M.
    De Chalus, T.
    Franca, Riou L.
    Claudepierre, P.
    VALUE IN HEALTH, 2013, 16 (07) : A556 - A556
  • [46] Certolizumab Pegol for Psoriasis and Psoriatic Arthritis
    Reddy, Vidhatha
    Thibodeaux, Quinn
    Koo, John
    CURRENT DERMATOLOGY REPORTS, 2020, 9 (02) : 100 - 106
  • [47] RAPID and FAST4WARD trials: certolizumab pegol for rheumatoid arthritis
    Ramiro, Sofia
    van Tubergen, Astrid M.
    Landewe, Robert B. M.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 713 - 720
  • [48] SYSTEMATIC REVIEW AND META-ANALYSIS ON CERTOLIZUMAB PEGOL FOR RHEUMATOID ARTHRITIS IN ADULTS
    Bernal, J. A.
    Vela, P.
    Ruiz Garcia, V.
    Burls, A.
    Cabello, J. B.
    Bort-Marti, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 557 - 557
  • [49] Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis
    Akito Nishimura
    Yohjiroh Minegishi
    Keiko Kwamura
    Asako Ichino
    Katsufumi Uchiyama
    Rheumatology International, 2015, 35 : 1601 - 1602
  • [50] DECLINE IN HEALTHCARE RESOURCE CONSUMPTION FOR PATIENTS WITH RHEUMATOID ARTHRITIS STARTING CERTOLIZUMAB PEGOL
    Saraux, A.
    Flipo, R.
    Fagnani, F.
    Cukierman, G.
    Joubert, J.
    Schuller, J.
    Massol, J.
    Combe, B.
    VALUE IN HEALTH, 2018, 21 : S301 - S301
12345